NCT05302921 2025-01-01Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid TumorsChildren's National Research InstitutePhase 2 Completed5 enrolled
NCT02982486 2017-11-01A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial CarcinomaAssaf-Harofeh Medical CenterPhase 2 Unknown60 enrolled